Search research articles
Contact Us
Filters
Showing results (521-530 of 786) with videos related to
Page
of 79
Sort By:
Bioorganic & Medicinal Chemistry
|
January 2, 2007
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors
Mark A Matulenko, Ernest S Paight, Robin R Frey, et al.
Veterinary Immunology and Immunopathology
|
September 9, 2008
Report of the 3rd Havemeyer workshop on allergic diseases of the Horse, Hólar, Iceland, June 2007
E Marti, V Gerber, A D Wilson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylase
Carol K Wada, Robin R Frey, Zhiqin Ji, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
Thienopyridine urea inhibitors of KDR kinase
H Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families
Michael L Curtin, Robin R Frey, H Robin Heyman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families
Keith B Glaser, Junling Li, Patrick A Marcotte, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Victoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry
|
October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target Engagement
Robin R Frey, Navendu Jana, Jacob V Gorman, et al.
Bioorganic & Medicinal Chemistry
|
May 3, 2005
5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors
Mark A Matulenko, Chih-Hung Lee, Meiqun Jiang, et al.
Science Translational Medicine
|
October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Page
of 79
Search research articles
Search
Showing results (521-530 of 786) with videos related to
Sort By:
Page
of 79
Bioorganic & Medicinal Chemistry
|
January 2, 2007
4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors
Mark A Matulenko, Ernest S Paight, Robin R Frey, et al.
Veterinary Immunology and Immunopathology
|
September 9, 2008
Report of the 3rd Havemeyer workshop on allergic diseases of the Horse, Hólar, Iceland, June 2007
E Marti, V Gerber, A D Wilson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylase
Carol K Wada, Robin R Frey, Zhiqin Ji, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
Thienopyridine urea inhibitors of KDR kinase
H Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families
Michael L Curtin, Robin R Frey, H Robin Heyman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families
Keith B Glaser, Junling Li, Patrick A Marcotte, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Victoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry
|
October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target Engagement
Robin R Frey, Navendu Jana, Jacob V Gorman, et al.
Bioorganic & Medicinal Chemistry
|
May 3, 2005
5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors
Mark A Matulenko, Chih-Hung Lee, Meiqun Jiang, et al.
Science Translational Medicine
|
October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Page
of 79